The Trp64Arg mutation of the adrenergic β-3 receptor gene impairs insulin secretion: A twin study

Diabetic Medicine

Volumn 16, Issue 10, 1999, Pages 835-840

  Christiansen, Christian ^a,b   Poulsen, P ^a   Beck Nielsen, H ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cell; Adrenergic 3 receptor; Insulin secretion; Oral glucose tolerance test; Trp64Arg mutation

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETOGENESIS; DIZYGOTIC TWINS; DOSE TIME EFFECT RELATION; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; STRUCTURE ACTIVITY RELATION;

AGED; ARGININE; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MUTATION; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN; TWINS, DIZYGOTIC;

EID: 0032748846     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00130.x     Document Type: Article

References (49)

1. 1 Strosberg AD. Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 1997; 37: 421-450.
2. 2 Emorine LJ, Blin N, Strosberg AD. The human beta 3-adrenoreceptor: the search for a physiological function. Trends Pharmacol Sci 1994; 15: 3-7.
3. 3 Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral far beta 3-adrenoceptors in obesity [see comments]. J Clin Invest 1995; 95: 1109-1116.
4. 4 Yoshida T, Yoshioka K, Hiraoka N, Umekawa T, Sakane N, Kondo M et al. Effect of CL 316,243, a novel beta 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreas. Endocr J 1994; 41: 671-675.
5. 5 Yoshida T. The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin. Am J Clin Nutr 1992; 55: 237S-41S.
6. 6 Sennitt MV, Arch JR, Levy AL, Simson DL, Smith SA, Cawthorne MA. Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenocepror agonist, in mice and rats. Biochem Pharmacol 1985; 34: 1279-1285.
7. 7 Revelli JP, Muzzin P, Paoloni A, Moinat M, Giacobino JP. Expression of the beta 3-adrenergic receptor in human white adipose tissue. J Mol Endocrinol 1993; 10: 193-197.
8. 8 Krief S, Lönnquist F, Raimbault S, Baube B, Van Spronsen A, Arner P et al. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 1993; 91: 344-349.
9. 9 Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555-560.
10. 10 Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistante syndrome in Finns. N Engl J Med 1995; 333: 348-351.
11. 11 Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343-347.
12. 12 Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y et al. Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349-352.
13. 13 Clement K, Vaisse C, Manning B, Basdevant A, Guy Grand B, Ruiz J et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-354.
14. 14 Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of non-insulin-dependent diabetes mellitus (NIDDM) and abnormal glucose tolerance - a population-based twin study. Diabetologia 1999, 42: 139-145.
15. 15 Magnus P, Berg K, Nance WE. Predicting zygosity in Norwegian twin pairs born 1915-60. Clin Gen 1983; 137: 335-343.
16. 16 Anonymous. Diabetes mellitus. Report of WHO study group. Techn Report Ser 1985; 727: 1-113.
17. 17 Hemmilae I, Dakubu S, Mukkala V-M, Siitari H, Loevgren T. Europium as a label in time-resolved imunoflourometric assays. Anal Biochem 1984; 137: 335-343.
18. 18 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
19. 19 Whittall R, Gudnasson V, Weavind GP, Day LB, Humphries SE, Day INM. Utilities for high throughput use of the single strand confirmation polymorphism method: screening of 791 patients with familial hypocholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor gene. J Med Genet 1995; 32: 509-515.
20. 20 Day INM, Humphries SE. Electrophoresis for genotyping: microtitre array diagonal gel electrophoresis (MADGE) on horizontal polyacrylamide (H-PAGE) gels, Hydrolink or agarose. Anal Biochem 1994; 222: 389-395.
21. 21 Sakane N, Yoshida T, Yoshioka K, Umekawa T, Takakura Y, Kogure A, Kondo M et al. Genetic variation in the beta 3-adrenergic receptor in Japanese NIDDM patients [letter]. Diabetes Care 1996; 19: 1034-1035.
22. 22 Garcia-Rubi E, Starling RD, Tchernof A, Matthews DE, Walston JD, Shuldiner AR et al. Trp64Arg variant of the beta 3-adrenoceptor and insulin resistance in obese postmenopausal women. J Clin Endocrinol Metab 1998; 83: 4002-4005.
23. 23 Rissanen J, Kuopusjärvi M, Pihlajamäki J, Sipiläinen R, Heikkinen S, Vanhala M et al. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 1997; 20: 1319-1323.
24. 24 Fujisawa T, Ikegami H, Yamato E, Hamada Y, Kamide K, Rakugi H et al. Trp64Arg mutation of beta 3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am J Hypertens 1997; 10: 101-105.
25. 25 Pihlajamaki J, Rissanen J, Valve R, Heikkinen S, Karjalainen L, Laakso M. Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta 3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia. Metabolism 1998; 47: 1397-1402.
26. 26 Arii K, Suehiro T, Yamamoto M, Ikeda Y, Nakauchi Y, Hashimoto K et al. Trp64Arg mutation of beta 3-adrenergic receptor and insulin sensitivity in subjects with glucose intolerance. Intern Med 1997; 36: 603-606.
27. 27 Sakane N, Yoshida T, Umekawa T, Kondo M, Sakai Y, Takahashi T. Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 1997; 40: 200-204.
28. 28 Kurabayashi T, Carey DG, Morrison NA. The beta 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996; 45: 1358-1363.
29. 29 Kim-Motoyama H, Yasuda K, Yamaguchi T, Yamada H, Katakura T, Shuldiner AR et al. A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 1997; 40: 469-472.
30. 30 Clement K, Ruiz J, Cassard Doulcier AM, Bouillard F, Ricquier D, Basdevant A et al. Additive effect of A→G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 1062-1066.
31. 31 Oksanen L, Mustajoki P, Kaprio J, Kainulainen K, Janne O, Peltonene L et al. Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 1055-1061.
32. 32 Yuan X, Yamada K, Koyama K, Ichikawa F, Ishiyama S, Koyanagi A et al. Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res Clin Pract 1997; 37: 1-7.
33. 33 Ueda K, Tanizawa Y, Oota Y, Inoue H, Kizuki N, Tsukuda K et al. Prevalence of the Trp64Arg missense mutation of the beta 3-adrenergic receptor gene in Japanese subjects. Metabolism 1997; 46: 199-202.
34. 34 Shiwaku K, Gao TQ, Isobe A, Fukushima T, Yamane Y. A Trp 64 Arg mutation in the beta 3-adrenergic receptor gene is not associated with moderate overweight in Japanese workers. Metabolism 1998; 47: 1528-1530.
35. 35 Sipilainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. Polymorphism of the beta 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 1997; 46: 77-80.
36. 36 Nagase T, Aoki A, Yamamoto M, Yasuda H, Kado S, Nishikawa M et al. Lack of association between the Trp64 Arg mutation in the beta 3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab 1997; 82: 1284-1287.
37. 37 Keen RW, Samaras K, Richens KL, Spector TD, Campbell LV, Kelly PJ. Beta 3-adrenergic receptor gene polymorphisms and determination of adiposity and fat distribution in normal female twins [letter]. Diabetologia 1997; 40: 122-123.
38. 38 Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT et al. The Trp64Arg mutation of the beta 3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996; 98: 2086-2093.
39. 39 Li LS, Lönnquist F, Luthman H, Arner P. Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996; 39: 857-860.
40. 40 Jeyasingam CL, Bryson JM, Caterson ID, Yue DK, Donnelly R. Expression of the beta 3-adrenoceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects. Clin Exp Pharmacol Physiol 1997; 24: 733-735.
41. 41 Yoneda H, Ikegami H, Yamamoto Y, Yamato E, Cha T, Kawaguchi Y et al. Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 1992; 15: 1517-1521.
42. 42 Kosaka K, Kuzuya T, Hagura R, Yoshinaga H. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 1996; 13: S109-S119.
43. 43 Walston J, Silver K, Martis H, Anderson S, Roth J, Shuldiner A. Glucose effectiveness and acute insulin response are impaired in individuals homozygous for the Arg 64 variant of the beta 3 adrenergic receptor. VII International Symposium on Insulin Receptors and Insulin Action, Jerusalem, Israel, 1998.
44. 44 Weyer C, Tataranni PA, Snitker S, Danforth EJ, Ravussin E. Increase in insulin action and fat oxidation after treatment with CL, 316,243, a highly selective beta 3-adrenoceptor agonist in humans. Diabetes 1998; 47: 1555-1561.
45. 45 Atef N, Lafontan M, Double A, Helary C, Ktorza A, Penicaud L. A specific beta 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats. Eur J Pharmacol 1996; 298: 287-292.
46. 46 Shankar R, Zhu J, Ladd B, Henry D, Shen H, Baron AD. Central nervous system nitric oxide synthase activity regulates insulin and insulin secretion. J Clin Invest 1998; 102: 1403-1412.
47. 47 Anthony A, Schepelmann S, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ et al. Localization of the beta-3 adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 1998; 12: 519-525.
48. 48 Gauthier C, Tavernier G, Charpentier F, Langin D, Le-Marec H. Functional beta-3 adrenoceptor in the human heart. J Clin Invest 1996; 98: 556-562.
49. 49 Berkowitz D, Nardone NA, Smiley RM, Price DT, Kreutter DK, Fremeau RT et al. Distribution of beta-3 adrenoceptor mRNA in human tissues. Eur J Pharmacol 1995; 289: 223-228.